Case report of compound oxidative phosphorylation deficiency type 10 caused by a new site mutation of MTO1 gene / 中华实用儿科临床杂志
Chinese Journal of Applied Clinical Pediatrics
; (24): 1026-1028, 2022.
Article
in Zh
| WPRIM
| ID: wpr-954683
Responsible library:
WPRO
ABSTRACT
The clinical data of a case of compound oxidative phosphorylation deficiency type 10 (COXPD10) caused by a new site mutation of MTO1 gene in the Department of Pediatrics, Affiliated Hospital of Southwest Medical University on December 29, 2020 were retrospectively analyzed.The patient was a 2 months and 19 days old boy of Han nationality.The main clinical manifestations were shortness of breath, hyperlactic acidemia, hyperammonemia and brain damage.Cardiac hypertrophy was not obvious.Heterozygous mutations at c. 344delA and c. 1055C>T sites in the MTO1 gene have not been reported in domestic and foreign literature.COXPD10 caused by MTO1 gene mutations may result in diversified clinical manifestations due to inconsistent mutation sites.For hyperlactic acidemia with unknown predisposing factors, early genetic examination should be conducted to confirm the possibility of COXPD10.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Chinese Journal of Applied Clinical Pediatrics
Year:
2022
Type:
Article